Abivax denies French media report of AstraZeneca takeover

Source

In this article

In this photo illustration, the Abivax logo is displayed on the screen of a tablet.
Sopa Images | Lightrocket | Getty Images

French biotech Abivax has told CNBC that it denied a French media report that AstraZeneca was in talks to acquire it.

The report by La Lettre said that AstraZeneca had had exclusive access to Abivax's data since early February and had until March 23 to formalize an offer. The publication cited "our sources."

Stock Chart Icon Stock chart icon
hide content
Abivax's shares.

The Abivax spokesperson told CNBC that they denied the report in its entirety but didn't comment further on the specific points in the article. AstraZeneca earlier declined to comment.

Abivax has been the subject of intense takeover speculation for months, and its stock price has soared as a result.

Shares were up as much as 15% on Thursday after the La Lettre report was published, but were about 4% in afternoon trading.

Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.